trial · primary record
YN001/Placebo 40mg
Atherosclerosis
| Phase | Phase 2 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 456 |
| Primary completion | 2029-03-31 |
| Primary endpoint | Relative change from baseline in coronary NCPV at Week 13 |
| Registry ID | NCT07521007 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T02:32:27.326Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07521007
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.